Diligence memo · auto-generated · as of July 2, 2026
Zyus Life Sciences Corp
Zyus Life Sciences Corp looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Zyus Life Sciences Corp operates in Other Health Care, based in SASKATOON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Zyus Life Sciences Corp has raised $692K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $574K on 2025-05-06.
Most recent recorded round closed around 2025-05-06.
Valuation (modeled)modeled
Provath models Zyus Life Sciences Corp at approximately $1.6M (range $360K–$4.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.92× the median modeled value of Pre-Seed Other Health Care companies in 2025–2027 (116 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 14 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 4.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 26% of Other Health Care peers (5377 compared).
Modeled value ranks above 9% of those peers.
Closest niche peers: 352 Ingredients LLC, Bmh North Mississippi Imaging Services Llc, ClearPath Vascular, Inc., Imagen Silvera Support Services, LLC, Mens LLC.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.